Weisberg Alan Jay's Form 4 filing
Progressive Care Inc. (RXMD) · filed Jan 6, 2022
- Accession no.
- 0001213900-22-000883
- Filed
- Jan 6, 2022, 10:13 AM ET
- Trade date
- Dec 9-14, 2021
- Filing delay
- 28 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions. Open-market purchases total $45.9K. It was filed 28 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Weisberg Alan JayCIK 0001383481 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 9, 2021 | Common Stock | PPurchaseAcquired | +692,462 | $0.031 | +$21,466.32 | 7,762,949 | Direct | |
| Dec 10, 2021 | Common Stock | PPurchaseAcquired | +92,559 | $0.032 | +$2,961.89 | 7,855,508 | Direct | |
| Dec 13, 2021 | Common Stock | PPurchaseAcquired | +437,451 | $0.03 | +$13,123.53 | 8,292,959 | Direct | |
| Dec 14, 2021 | Common Stock | PPurchaseAcquired | +277,528 | $0.03 | +$8,325.84 | 8,570,487 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.
Remarks
This Form 4 is being filed on a voluntary basis.